Related Experiment Video
Updated: Jan 30, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
Epithelial-mesenchymal transition as a target for botanicals in cancer metastasis
Bahare Salehi1, Elena Maria Varoni2, Mehdi Sharifi-Rad3
1Medical Ethics and Law Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Background:
The plant kingdom represents an unlimited source of phytotherapeutics with promising perspectives in the field of anticancer drug discovery.
Purpose:
In this view, epithelial-mesenchymal transition (EMT) represents a novel and major target in anticancer therapy. Therefore, this narrative review aims to provide an updated overview on the bioactive phytochemicals with anti-EMT activity.
Conclusion:
Among the plant products reviewed, phenylpropanoids were the most investigated at preclinical phase, thus exhibiting a promising potential as anticancer drugs, though an evidence-based clinical efficacy is still lacking.
Insights
Plants offer promising anticancer drugs by targeting epithelial-mesenchymal transition (EMT). Phenylpropanoids show potential, but clinical evidence is needed.
Area of Science:
- Phytochemistry
- Oncology
- Drug Discovery
Background:
- The plant kingdom is a rich source of phytotherapeutics for anticancer drug discovery.
- Epithelial-mesenchymal transition (EMT) is a key process in cancer progression and metastasis.
- Targeting EMT offers a novel therapeutic strategy in cancer treatment.
Purpose of the Study:
- To review bioactive phytochemicals with anti-epithelial-mesenchymal transition (EMT) activity.
- To provide an updated overview of natural compounds targeting EMT in cancer therapy.
Main Methods:
- Narrative review of scientific literature.
- Focus on preclinical and clinical studies of phytochemicals and their anti-EMT effects.
Main Results:
- Phenylpropanoids were the most studied phytochemical class with anti-EMT activity.
- Several plant-derived compounds demonstrated significant preclinical anti-EMT effects.
Conclusions:
- Phenylpropanoids show promising anticancer potential by targeting EMT.
- Further clinical research is required to establish the efficacy of these phytotherapeutics in cancer patients.
Related Concept Videos
Phase Transitions
Targeted Cancer Therapies
There are several types of targeted therapies against...
Properties of Transition Metals
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cooperative Allosteric Transitions
Phase Transitions: Vaporization and Condensation

